A microsimulation of the cost-effectiveness of maraviroc for antiretroviral treatment-experienced HIV-infected individuals from an Italian perspective
HomePublicationsA microsimulation of the cost-effectiveness of maraviroc for antiretroviral treatment-experienced HIV-infected individuals from an Italian perspective